172 related articles for article (PubMed ID: 9259693)
21. ESRD modality selection into the 21st century: the importance of non medical factors.
Nissenson AR; Prichard SS; Cheng IK; Gokal R; Kubota M; Maiorca R; Riella MC; Rottembourg J; Stewart JH
ASAIO J; 1997; 43(3):143-50. PubMed ID: 9152482
[No Abstract] [Full Text] [Related]
22. Recombinant erythropoietin. The effect of the marketplace on socialized patient care.
Besarab A; Erslev AJ
ASAIO J; 1993; 39(2):85-6. PubMed ID: 8324265
[No Abstract] [Full Text] [Related]
23. Pediatric end-stage renal disease. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S98-108. PubMed ID: 9713412
[No Abstract] [Full Text] [Related]
24. Race and access to erythropoietin by patients on hemodialysis.
Sadler JH
JAMA; 1994 Dec; 272(23):1818-9. PubMed ID: 7990207
[No Abstract] [Full Text] [Related]
25. Analytical methods. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S142-62. PubMed ID: 9713417
[No Abstract] [Full Text] [Related]
26. Patient mortality and survival. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S69-80. PubMed ID: 9713409
[No Abstract] [Full Text] [Related]
27. USRDS: the United States Renal Data System.
Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):1-230. PubMed ID: 14655174
[No Abstract] [Full Text] [Related]
28. Renal transplantation: access and outcomes. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S118-27. PubMed ID: 9259697
[No Abstract] [Full Text] [Related]
29. Incidence and prevalence of ESRD. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S38-49. PubMed ID: 9713406
[No Abstract] [Full Text] [Related]
30. Peritoneal Dialysis or Hemodialysis: Present and Future Trends in the United States.
Kaplan AA
Contrib Nephrol; 2017; 189():61-64. PubMed ID: 27951550
[TBL] [Abstract][Full Text] [Related]
31. 1998 U.S. Renal Data System Report/Part II. Living unrelated donor rate grew 46% annually from 1993-96; hospitalizations higher for pediatric HD vs. PD patients.
Nephrol News Issues; 1998 Oct; 12(10):62-3. PubMed ID: 10196958
[No Abstract] [Full Text] [Related]
32. Description of the USRDS and its data base.
Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):17-20. PubMed ID: 1951353
[No Abstract] [Full Text] [Related]
33. Quantity and quality of ESRD treatment in the United States of America.
Sadler J
Contrib Nephrol; 1990; 78():181-5. PubMed ID: 2225835
[No Abstract] [Full Text] [Related]
34. The Role of Big Data in the Development and Evaluation of US Dialysis Care.
Erickson KF; Qureshi S; Winkelmayer WC
Am J Kidney Dis; 2018 Oct; 72(4):560-568. PubMed ID: 29921451
[TBL] [Abstract][Full Text] [Related]
35. A comparison of transplant outcomes in peritoneal and hemodialysis patients.
Snyder JJ; Kasiske BL; Gilbertson DT; Collins AJ
Kidney Int; 2002 Oct; 62(4):1423-30. PubMed ID: 12234315
[TBL] [Abstract][Full Text] [Related]
36. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
37. The ESRD regulatory landscape: a primer and resource. Part 1.
Robers S
Nephrol News Issues; 2002 Dec; 16(13):29-33, 53. PubMed ID: 12596328
[No Abstract] [Full Text] [Related]
38. Excluded from universal coverage: ESRD patients not covered by Medicare.
Thamer M; Ray NF; Richard C; Greer JW; Pearson BC; Cotter DJ
Health Care Financ Rev; 1995; 17(2):123-46. PubMed ID: 10157372
[TBL] [Abstract][Full Text] [Related]
39. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
Port FK
Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
[TBL] [Abstract][Full Text] [Related]
40. Selected research topics.
Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):96-104. PubMed ID: 1951363
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
